Derlin-1 Promotes the Progression of Human Hepatocellular Carcinoma via the Activation of AKT Pathway.
Jiye FanLiying TianShuhong HuangJing ZhangBaohua ZhaoPublished in: OncoTargets and therapy (2020)
Our findings prove that DERL1 promotes tumor progression via AKT pathway and provide a new potential target for the clinical treatment and diagnosis of human HCC.